SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Designed for symptomatic individuals within six days of symptom onset, the QuickVue COVID-19 test is cleared for use in individuals aged 14 or older when self-testing, and in those aged two and older ...
(RTTNews) - QuidelOrtho (QDEL) said it has received FDA 510(k) clearance for QuickVue COVID-19 test. The clearance allows the test to be used in home and medical facility settings with CLIA ...
Add Yahoo as a preferred source to see more of our stories on Google. Covid-19 at home Rapid Test Kit The FDA has extended the shelf life for some COVID-19 tests. Now that allergy season is here, many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results